AscellaHealth Launches Biopharmaceutical Educational Podcast Workshop Series, Partnering with National Association of Specialty Pharmacy & Pharmacy Podcast Network

AscellaHealth, a global healthcare and specialty pharmacy solutions company, today celebrates Rare Disease Day, raising awareness of the 7,000+ rare diseases that impact over 300 million people globally, and announces its upcoming six part Biopharmaceutical Educational Podcast Workshop Series 2023. The first episode "Insights Into The Rare-Ultra Orphan Market & The Challenges for Manufacturers, Providers, Payers, Pharmacies and Patients," hosted by Michael Baldzicki, CRCM and chief brand officer, AscellaHealth and featuring Thomas Cohn, chief strategy officer, Asembia and Nick Calla, Sr. vice president industry relations, Orsini Healthcare, premiers live at the AXS23 Summit, Wednesday, May 3rd, 2023, at 3:30 PM EST.

"Together with our esteemed partners, Pharmacy Podcast Network (PPN) and the National Association of Specialty Pharmacy (NASP), we will bring listeners a series of podcasts that will articulate the evolution of the orphan drug and gene/cell therapy markets as they capture a significant focus of the specialty pharmacy industry," says Dea Belazi, president and CEO, AscellaHealth. "Our distinguished panel of presenters will discuss the latest trends in rare disease / orphan drug market access, assess current payer perspectives and offer insights and potential implications of the management of rare disease and orphan drugs. We are delighted and grateful to all of our featured podcast guests who will support AscellaHealth in bringing this valuable series to all industry stakeholders, including manufacturers., payers, providers and patients.

Click here for information on additional episodes in the podcast series, including:

• Episode 2: Insights into the (CGT) Cell/Gene Therapy Market & Challenges Facing Market Entrants and Commercialization
  Thursday, June 15th, 2023, at 1:30 PM EST featuring Michelle Rice, CEO, Michelle Rice & Associates and Kenneth Mankowski, DO, FACN, MS Neurologist Specialist, CNS & MS Institute
  

• Episode 3: Why Rare-Ultra Orphan Therapies Need Early Market Access Planning and Innovative Solutions
  Thursday, July 13th 2023, at 1:30 PM EST featuring Jim Clement, partner and board member, Coeus Holdings and Donovan Quill, executive vice president, AscellaHealth
  

• Episode 4: The Economic and Clinical Value for Market Access and Ensuring Entree to Therapy
  Thursday, August 3rd, 2023, at 1:30 PM EST featuring Brandon Salke, PharmD, CSP, general manager, Optime Care, subsidiary of AscellaHealth, and Elizabeth Johnson, CEO, MedicoCX, Co-CEO, HAS, and co-founder and president, National Association of Medication Access and Patient Advocacy (NAMAPA)
  

• Episode 5: The Evolution of Specialty Pharmacy & Hospital Specialty Pharmacies For Rare-Ultra Orphan Drugs and Gene & Cell Therapies
  Wednesday, September 20th, 2023, at 3:00 PM EST live at the NASP Annual Meeting & Expo featuring Edie Gigot, Sr. vice president of pharmacy, Flexcare Infusion Center and Chandra Wahrgren, SVP of pharmacy enterprise & innovation, Moda Partners
  

• Episode 6: The Distribution Channel and Pharmacy Network Optimization Towards Addressing The Need for High Acuity Of Care and Service For Rare-Ultra Orphan Therapies
  Thursday, October 26th, 2023, at 1:30 PM EST Chris Ford, chief innovation officer, Synergie Medication Collective and Kyle Skiermont, PharmD, vice president of pharmacy, Nebraska Medicine & Hub

If you would like to become a sponsor of the Biopharmaceutical Educational Podcast Workshop Series 2023, click here: https://pharmacypodcast.com/2023/02/25/biopharmaceutical-educational-podcast-workshop-series-2023/

If you are interested in meeting with AscellaHealth at AXS23Summit, please contact us at [email protected].

About AscellaHealth LLC

AscellaHealth is a global Healthcare & Specialty Pharmacy solutions organization serving patients, life sciences manufacturers, payers and providers, offering a comprehensive portfolio of customized, tech-enabled specialty pharmaceutical and personalized medical management services. A multiple Inc. 5000 winner and NASP 2022 Strategic Channel Partner of the Year award winner, AscellaHealth's unique, patient-centric approach is built upon proprietary technology processes for innovative programs and services optimizing health outcomes and quality of life for patients with complex chronic conditions or rare diseases that require specialty medications and/or cell and gene therapies. Visit www.AscellaHealth.com.